Want to see AU:CYP full AI Analyst Report?
Cynata Therapeutics Limited (CYP) Income Statement
Cynata Therapeutics Limited Income Statement
Last quarter (Q4 2026), Cynata Therapeutics Limited's total revenue was $0.00, an increase of 100.00% from the same quarter last year. In Q4, Cynata Therapeutics Limited's net income was $-6.59M. See Cynata Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 1.71M | $ 1.89M | $ 2.32M | $ 1.65M | $ 7.77M | |
| $ -260.31K | $ 1.89M | $ 2.32M | $ 1.37M | $ 7.49M | |
| $ 9.42M | $ 10.01M | $ 11.12M | $ 16.26M | $ 12.06M | |
| Depreciation and Amortization | $ 260.31K | $ 282.96K | $ 280.73K | $ 279.96K | $ 279.96K |
| $ -9.42M | $ -9.33M | $ -9.95M | $ -15.65M | $ -6.00M | |
| $ -9.68M | $ -8.12M | $ -8.81M | $ -16.54M | $ -6.90M | |
| $ -1.28M | $ -1.27M | $ -3.25M | $ 610.71K | $ 622.45K | |
| $ -10.96M | $ -9.39M | $ -12.06M | $ -15.93M | $ -6.28M | |
| $ -9.25M | $ -9.39M | $ -9.74M | $ -14.28M | $ -5.45M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.04 | $ -0.05 | $ -0.05 | $ -0.10 | $ -0.04 |
| Diluted EPS | $ -0.04 | $ -0.05 | $ -0.05 | $ -0.10 | $ -0.04 |
| Weighted Average Shares Outstanding | 236.70M | 204.95M | 179.63M | 145.09M | 143.28M |
| Weighted Average Shares Outstanding (Diluted) | 236.70M | 204.95M | 179.63M | 145.09M | 143.28M |
Currency in AUD
